Cargando…

Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer

Introduction: Breast cancer is the most common cancer in women, with roughly 10–15% of new cases classified as triple-negative breast cancer (TNBC). Traditional chemotherapies are often toxic to normal cells. Therefore, it is important to discover new anticancer compounds that target TNBC while caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Shradheya R. R., Ta, Tram M., Khan, Maryam, Singh, Archana, Singh, Indrakant K., Peethambaran, Bela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534069/ https://www.ncbi.nlm.nih.gov/pubmed/37779899 http://dx.doi.org/10.3389/fcell.2023.1243763

Ejemplares similares

Relevance Function of Linc-ROR in the Pathogenesis of Cancer
por: Chen, Wenjian, et al.
Publicado: (2020)

The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease
por: Endo, Mitsuharu, et al.
Publicado: (2022)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2021)

Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response
por: Furlong, Suzanne, et al.
Publicado: (2018)

Heterozygous Recurrent Mutations Inducing Dysfunction of ROR2 Gene in Patients With Short Stature
por: Gui, Baoheng, et al.
Publicado: (2021)

Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells
por: Dave, Zankruti, et al.
Publicado: (2022)

Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1
por: Teo, Wee S., et al.
Publicado: (2020)

The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2022)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
por: Olsson, Maxim, et al.
Publicado: (2023)

Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer
por: Guo, Maoni, et al.
Publicado: (2021)

Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells
por: Rosado-Galindo, Heizel, et al.
Publicado: (2023)

Crude Cell-Free Extract From Deinococcus radiodurans Exhibit Anticancer Activity by Inducing Apoptosis in Triple-Negative Breast Cancer Cells
por: Maqbool, Illiyas, et al.
Publicado: (2020)

Morphological Phenotyping of Organotropic Brain- and Bone-Seeking Triple Negative Metastatic Breast Tumor Cells
por: DeCastro, Ariana Joy L., et al.
Publicado: (2022)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
por: Liao, Gaoming, et al.
Publicado: (2022)

Blimp-1/PRDM1 and Hr3/RORβ specify the blue-sensitive photoreceptor subtype in Drosophila by repressing the hippo pathway
por: Bunker, Joseph, et al.
Publicado: (2023)

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research
por: Yan, Shunchao, et al.
Publicado: (2023)

Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer
por: Geng, Peizhen, et al.
Publicado: (2023)

A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation
por: Bernatik, Ondrej, et al.
Publicado: (2017)

Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells
por: Di Donato, Marzia, et al.
Publicado: (2021)

Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human
por: Zhao, Weipeng, et al.
Publicado: (2021)

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin
por: Granit, Avital, et al.
Publicado: (2022)

Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
por: Granit Mizrahi, Avital, et al.
Publicado: (2023)

Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer
por: Huang, Zhidong, et al.
Publicado: (2021)

The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer
por: Wang, Qingshui, et al.
Publicado: (2021)

Screening and diagnosis of triple negative breast cancer based on rapid metabolic fingerprinting by conductive polymer spray ionization mass spectrometry and machine learning
por: Song, Yaoyao, et al.
Publicado: (2022)

Sustained IP3-linked Ca(2+) signaling promotes progression of triple negative breast cancer cells by regulating fatty acid metabolism
por: Filadi, Riccardo, et al.
Publicado: (2023)

Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
por: Chen, Zhuohui, et al.
Publicado: (2021)

LncRNA GHET1 Promotes Hypoxia-Induced Glycolysis, Proliferation, and Invasion in Triple-Negative Breast Cancer Through the Hippo/YAP Signaling Pathway
por: Wang, Yu, et al.
Publicado: (2021)

Huaier Induces Immunogenic Cell Death Via CircCLASP1/PKR/eIF2α Signaling Pathway in Triple Negative Breast Cancer
por: Li, Chen, et al.
Publicado: (2022)

Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
por: Gupta, Ishita, et al.
Publicado: (2018)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
por: Fultang, Norman, et al.
Publicado: (2019)

Inter-organ Wingless/Ror/Akt signaling regulates nutrient-dependent hyperarborization of somatosensory neurons
por: Kanaoka, Yasutetsu, et al.
Publicado: (2023)

Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway
por: Wu, Hao, et al.
Publicado: (2021)

Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
por: Illendula, Abhinav, et al.
Publicado: (2020)

Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates
por: Susman, Michael W, et al.
Publicado: (2017)

Long Non-coding RNA SENP3-EIF4A1 Functions as a Sponge of miR-195-5p to Drive Triple-Negative Breast Cancer Progress by Overexpressing CCNE1
por: Chen, Lie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_igc19kqc3gv2qfort5537d5ms3